{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:39:47Z","timestamp":1792571987413,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05739-z","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:55:15Z","timestamp":1789811715000},"page":"5545-5561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SERPINE1 promotes CRC cell invasion and metastasis through resistance to anoikis"],"prefix":"10.1007","volume":"481","author":[{"given":"Yaru","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linying","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"3","key":"5739_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5739_CR2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3748\/wjg.v29.i9.1395","volume":"29","author":"S Al Bitar","year":"2023","unstructured":"Al Bitar S et al (2023) Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: updates and beyond. World J Gastroenterol 29(9):1395\u20131426","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5739_CR3","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1038\/s41467-023-41011-4","volume":"14","author":"AJ Ohnmacht","year":"2023","unstructured":"Ohnmacht AJ et al (2023) The oncology biomarker discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. Nat Commun 14(1):5391","journal-title":"Nat Commun"},{"issue":"3","key":"5739_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH (2022) Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology 162(3):715-730e3","journal-title":"Gastroenterology"},{"issue":"6","key":"5739_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3748\/wjg.v29.i6.926","volume":"29","author":"YL Tang","year":"2023","unstructured":"Tang YL et al (2023) Resistance to targeted therapy in metastatic colorectal cancer: current status and new developments. World J Gastroenterol 29(6):926\u2013948","journal-title":"World J Gastroenterol"},{"issue":"2","key":"5739_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18(2):99\u2013115","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"5739_CR7","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79(18):4557\u20134566","journal-title":"Cancer Res"},{"issue":"1","key":"5739_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL (2020) The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther 5(1):166","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"5739_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E et al (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759\u2013771","journal-title":"Nat Rev Cancer"},{"key":"5739_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.699842","volume":"12","author":"C Buhrmann","year":"2021","unstructured":"Buhrmann C et al (2021) Evidence that tumor microenvironment initiates epithelial-to-mesenchymal transition and calebin A can suppress it in colorectal cancer cells. Front Pharmacol 12:699842","journal-title":"Front Pharmacol"},{"issue":"4","key":"5739_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK (2023) Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci 44(4):222\u2013236","journal-title":"Trends Pharmacol Sci"},{"key":"5739_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.semcdb.2014.09.008","volume":"36","author":"TA Martin","year":"2014","unstructured":"Martin TA (2014) The role of tight junctions in cancer metastasis. Semin Cell Dev Biol 36:224\u2013231","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"5739_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir B et al (2020) EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol 30(10):764\u2013776","journal-title":"Trends Cell Biol"},{"issue":"6","key":"5739_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM et al (2018) EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell 45(6):681-695e4","journal-title":"Dev Cell"},{"issue":"3","key":"5739_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/nu8030145","volume":"8","author":"C Buhrmann","year":"2016","unstructured":"Buhrmann C et al (2016) Sirt1 is required for resveratrol-mediated chemopreventive effects in colorectal cancer cells. Nutrients 8(3):145","journal-title":"Nutrients"},{"issue":"14","key":"5739_CR16","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.7150\/ijbs.25720","volume":"14","author":"S Guo","year":"2018","unstructured":"Guo S, Deng CX (2018) Effect of stromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci 14(14):2083\u20132093","journal-title":"Int J Biol Sci"},{"issue":"17","key":"5739_CR17","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","volume":"27","author":"M Taki","year":"2021","unstructured":"Taki M et al (2021) Tumor immune microenvironment during epithelial-mesenchymal transition. Clin Cancer Res 27(17):4669\u20134679","journal-title":"Clin Cancer Res"},{"key":"5739_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114395","volume":"160","author":"E Sabouni","year":"2023","unstructured":"Sabouni E et al (2023) Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: metastasis, therapy response, and revisiting molecular pathways. Biomed Pharmacother 160:114395","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5739_CR19","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1002\/jcp.30142","volume":"236","author":"S Wang","year":"2021","unstructured":"Wang S et al (2021) cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP. J Cell Physiol 236(5):3963\u20133978","journal-title":"J Cell Physiol"},{"issue":"1","key":"5739_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi E, Satija R (2018) Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol 18(1):35\u201345","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"5739_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1158\/2326-6066.CIR-18-0658","volume":"7","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhang Z (2019) Recharacterizing tumor-infiltrating lymphocytes by single-cell RNA sequencing. Cancer Immunol Res 7(7):1040\u20131046","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"5739_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan Z et al (2023) Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer 22(1):48","journal-title":"Mol Cancer"},{"issue":"4","key":"5739_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer CL et al (2016) EMT, cell plasticity and metastasis. Cancer Metastasis Rev 35(4):645\u2013654","journal-title":"Cancer Metastasis Rev"},{"issue":"24","key":"5739_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf5464","volume":"9","author":"F Wang","year":"2023","unstructured":"Wang F et al (2023) Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer. Sci Adv 9(24):eadf5464","journal-title":"Sci Adv"},{"issue":"5","key":"5739_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","volume":"24","author":"S Kamali Zonouzi","year":"2022","unstructured":"Kamali Zonouzi S et al (2022) Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol 24(5):757\u2013769","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"5739_CR26","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1158\/1078-0432.CCR-16-2554","volume":"23","author":"ZY Dong","year":"2017","unstructured":"Dong ZY et al (2017) Potential predictive Value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma. Clin Cancer Res 23(12):3012\u20133024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5739_CR27","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1038\/s41598-023-32457-z","volume":"13","author":"Q Luo","year":"2023","unstructured":"Luo Q et al (2023) Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment. Sci Rep 13(1):5106","journal-title":"Sci Rep"},{"key":"5739_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107432","volume":"166","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses. Comput Biol Med 166:107432","journal-title":"Comput Biol Med"},{"issue":"1","key":"5739_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-016-0427-7","volume":"35","author":"G Song","year":"2016","unstructured":"Song G et al (2016) TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K\/AKT and MAPK pathway. J Exp Clin Cancer Res 35(1):148","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"5739_CR30","doi-asserted-by":"publisher","first-page":"8998","DOI":"10.18632\/aging.102366","volume":"11","author":"L Yang","year":"2019","unstructured":"Yang L et al (2019) TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer. Aging 11(20):8998\u20139012","journal-title":"Aging"},{"issue":"12","key":"5739_CR31","first-page":"1889","volume":"54","author":"L Du","year":"2022","unstructured":"Du L et al (2022) ZNF3 regulates proliferation, migration and invasion through MMP1 and TWIST in colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 54(12):1889\u20131896","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"5739_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031181","author":"L Ng","year":"2022","unstructured":"Ng L et al (2022) CD26 induces colorectal cancer angiogenesis and metastasis through CAV1\/MMP1 signaling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031181","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5739_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.211","volume":"10","author":"P Yang","year":"2020","unstructured":"Yang P et al (2020) TCONS_00012883 promotes proliferation and metastasis via DDX3\/YY1\/MMP1\/PI3K-AKT axis in colorectal cancer. Clin Transl Med 10(6):e211","journal-title":"Clin Transl Med"},{"key":"5739_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157435","volume":"148","author":"Y Wei","year":"2025","unstructured":"Wei Y et al (2025) Fuzheng YiLiu decoction promote colorectal cancer apoptosis and reduce its proliferation via IGF2\/IGF1R\/PI3K\/AKT pathway. Phytomedicine 148:157435","journal-title":"Phytomedicine"},{"issue":"2","key":"5739_CR35","first-page":"473","volume":"55","author":"L Wang","year":"2019","unstructured":"Wang L et al (2019) Cystathionine\u2013\u03b3\u2013lyase promotes the metastasis of breast cancer via the VEGF signaling pathway. Int J Oncol 55(2):473\u2013487","journal-title":"Int J Oncol"},{"issue":"13","key":"5739_CR36","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1158\/1078-0432.CCR-24-3848","volume":"31","author":"H Werneck Gomes","year":"2025","unstructured":"Werneck Gomes H et al (2025) p-AKT protein expression predicts response to AKT inhibitor combined with docetaxel therapy in adenocarcinoma and neuroendocrine prostate cancer. Clin Cancer Res 31(13):2727\u20132740","journal-title":"Clin Cancer Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05739-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:55:40Z","timestamp":1792569340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5739"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05739-z","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki. This study passed the ethical review of Shanghai East Hospital affiliated to Tongji University(2024YS-291). All patients signed the informed consent form. This study did not involve any animal experiments.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study fully obtained the informed consent from patients.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}